Page last updated: 2024-12-09

geldanamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5363342
CHEBI ID91572
SCHEMBL ID13018038
MeSH IDM0041388
PubMed CID5288382
CHEBI ID5292
CHEBI ID91381
SCHEMBL ID13037476
SCHEMBL ID4154
MeSH IDM0041388

Synonyms (61)

Synonym
geldanamycin ,
13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
SCHEMBL13018038
QTQAWLPCGQOSGP-RKOUBUDQSA-N
13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate #
geldaramycin
CHEBI:91572
[(4e,6z,10e)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
BS-1610
nsc-122750
BSPBIO_001073
[(3s,5s,6r,7s,8e,10r,11s,12z,14e)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate
nsc 122750
brn 1633093
IDI1_002122
gdm ,
2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, [8s-(4e,6z,8r*,9r*,10e,12r*,13s*,14r*,16s*)]-
2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9,13-dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, 9-carbamate (8ci)
[8s-(4e,6z,8r*,9r*,10e,12r*,13s*,14r*,16s*)]-9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione
geldanamycin (9ci)
gmy ,
u-29135
2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, (4e,6z,8s,9s,10e,12s,13r,14s,16r)-
(4e,6z,8s,9s,10e,12s,13r,14s,16r)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
DB02424
NCGC00163449-02
NCGC00163449-01
[(3r,5s,6r,7s,8e,10s,11s,12z,14e)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate
HMS1990E15
G0334
chebi:5292 ,
HMS1792E15
HMS1362E15
unii-z3k3vj16ku
u 29135
z3k3vj16ku ,
geldanamycin from streptomyces hygroscopicus
1YET
geldanamycin [mi]
BRD-K11528507-001-01-8
SCHEMBL13037476
CCG-208040
EI-280
SCHEMBL4154
DTXSID7042691
QTQAWLPCGQOSGP-KSRBKZBZSA-N
bdbm50008059
AKOS024456552
HMS3403E15
mfcd00274570
J-521410
CHEBI:91381
geldanamycin from streptomyces hygroscopicus, >=98% (hplc), powder
SR-05000002266-3
sr-05000002266
J-018017
gtpl9829
geldanamycin, streptomyces hygroscopicus - cas 30562-34-6
[(4e,6z,8s,9s,10e,12s,13r,14s,16r)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
A1-50253
Z2568648438

Research Excerpts

Toxicity

Experiments on rat liver slices demonstrated the differential hepatobiliary toxic potency of two anticancer agents, geldanamycin (GEL) and 17-allylaminogeldan Amycin (17-AAG), over a 5-day period.

ExcerptReferenceRelevance
"Previously, we reported that several of the toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) were not fully expressed in c-src -/- and -/+ mice (1)."( Use of c-Src and c-Fos knockout mice for the studies on the role of c-Src kinase signaling in the expression of toxicity of TCDD.
Dunlap, DY; Enan, E; Matsumura, F, 1998
)
0.3
" All adverse effects were fully reversible in surviving animals after treatment was complete."( Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
Brown, AP; Covey, JM; Egorin, MJ; Eiseman, JL; Glaze, ER; Holleran, JL; Johnson, WD; Lambert, AL; Levine, BS; McCormick, DL; Page, JG; Sausville, EA; Smith, AC; Tomaszewski, JE, 2005
)
0.33
"Experiments on rat liver slices demonstrated the differential hepatobiliary toxic potency of two anticancer agents, geldanamycin (GEL) and 17-allylaminogeldanamycin (17-AAG), over a 5-day period."( In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin using dog liver slices.
Amin, K; Behrsing, H; Ip, C; Jimenez, L; Tyson, C, 2005
)
0.33
" Slices exposed to the same concentrations were more sensitive to toxic effects of GEL than of 17-AAG."( In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin in rats.
Amin, K; Behrsing, HP; Ip, C; Jimenez, L; Tyson, CA, 2005
)
0.33
" GA was toxic to E47 cells and SB203580, an inhibitor of p38 MAPK prevented this decrease in viability."( Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathway.
Cederbaum, AI; Dey, A, 2007
)
0.34
" High concentrations of APC (>50 nM) induced the death of hippocampal neurons similarly to the toxic action of glutamate."( Activated protein C via PAR1 receptor regulates survival of neurons under conditions of glutamate excitotoxicity.
Davydova, ON; Gorbacheva, LR; Ishiwata, S; Pinelis, VG; Storozhevykh, TP; Strukova, SM, 2008
)
0.35
" In this study, we tested the hypothesis that the low lysosomal pH of normal cells plays an important role in protecting normal tissues from the toxic effects of lysosomotropic anticancer drugs."( The role of lysosomes in limiting drug toxicity in mice.
Forrest, ML; Krise, JP; Ndolo, RA, 2010
)
0.36
" Because of its adverse effects on liver, its less toxic derivatives 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) are currently being evaluated for the treatment of cancer."( Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs.
Goldstein, S; Hyodo, F; Ishii, H; Krishna, MC; Mitchell, JB; Samuni, U; Samuni, Y, 2010
)
0.36
" Although sunitinib is effective for the treatment of patients with gastrointestinal stromal tumor, advanced renal cell carcinoma, or pancreatic neuroendocrine tumor, adverse cardiac events associated with sunitinib administration have been reported."( Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.
Kimura, T; Miyamoto, N; Sawada, K; Takase, K; Uesugi, M, 2017
)
0.46

Pharmacokinetics

ExcerptReferenceRelevance
"There is an urgent need to develop non-invasive pharmacodynamic endpoints for the evaluation of new molecular therapeutics that inhibit signal transduction."( Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.
Aboagye, EO; Hutchinson, OC; Liu, D; Osman, S; Price, P; Workman, P, 2002
)
0.31
" Plasma and tissue pharmacokinetic parameters were evaluated by non-compartmental analysis."( Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Hayes, A; Nutley, BP; Raynaud, FI; Smith, NF; Workman, P, 2004
)
0.32
" In addition, the plasma area under the curve (AUC) and the half-life of these compounds was greater following cassette dosing at 5 mg/kg compared to single administration at the same dose."( Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Hayes, A; Nutley, BP; Raynaud, FI; Smith, NF; Workman, P, 2004
)
0.32
"We have used a semimechanistic pharmacodynamic model to characterize concentration-effect relationships of ATO and HSP90 inhibitors on constitutive STAT3 activity, HSP70 expression, and cell death in a cell line model."( Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling.
Brady, MT; Earp, JC; Jusko, WJ; Keng, MK; Wetzler, M, 2007
)
0.34
" To understand the complexity and to explore optimal therapeutic regimens for ADEPT in vivo, a physiologically based pharmacokinetic model (PBPK) is applied to analyze each anatomical component/organ."( Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy.
Fang, L; Sun, D, 2008
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
" In this study, we showed that oxygen-glucose deprivation (OGD) combined with a caspase inhibitor zVAD (OGD/zVAD)-induced RIP1 protein expression in a time-dependent manner."( RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons.
Chen, WW; Cheng, Y; Fan, HB; Geng, D; Kong, J; Liu, CF; Xu, X; Yu, H; Zhang, C; Zhang, CC; Zhang, M, 2012
)
0.38
"A standardized broth microdilution method was used to test the antifungal activity of geldanamycin (GA), an inhibitor of heat shock protein 90 (Hsp90), alone or in combination with the antifungal agent fluconazole (FLC) against 32 clinical isolates of Candida spp."( Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.
Li, R; Liu, W; Sun, Y; Tan, J; Wan, Z; Zhang, J, 2013
)
0.39
" To recapitulate a clinical context where Hsp90 or calcineurin inhibitors could be utilized in combination with azoles to render resistant pathogens responsive to treatment, the evolution experiment was initiated with strains that are resistant to azoles in a manner that depends on Hsp90 and calcineurin."( Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations.
Ammar, R; Cowen, LE; Hill, JA; Nislow, C; Torti, D, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"A decline in the bioavailability of nitric oxide (NO) that causes endothelial dysfunction is a hallmark of diabetes."( High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction.
Centonze, VE; Konopinski, R; Mohan, S; Natarajan, M; Yan, B, 2009
)
0.35

Dosage Studied

17-(allylamino)-17-demethoxygeldanamycin and other 17-amino analogs were effective at reducing p185 phosphotyrosine in subcutaneous flank FRE/erbB-2 tumors. cassette dosing has advantages for use in drug discovery, it is probably unsuitable to evaluate the pharmacokinetics of geldan amycin analogues due to non-linear pharmacokinetic and drug-drug interaction.

ExcerptRelevanceReference
" Specifically, dosed intraperitoneally at 100 mg/kg, 17-(allylamino)-17-demethoxygeldanamycin and other 17-amino analogs were effective at reducing p185 phosphotyrosine in subcutaneous flank FRE/erbB-2 tumors."( Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
Barbacci, EG; Cooper, BA; Corman, ML; Dee, MF; DiOrio, CI; Doty, JL; Gallaschun, RJ; Moyer, JD; Muzzi, ML; Schnur, RC, 1995
)
0.29
" HeLa and Hepa 1c1c7 cells were subjected to a dose-response and time-course treatment with GA and the level of the AhR was determined."( The Ah receptor is a sensitive target of geldanamycin-induced protein turnover.
Chen, HS; Perdew, GH; Singh, SS, 1997
)
0.3
" Thus, ligand-independent translocation of the AHR to the nucleus was not sufficient to induce CYP1A1 in the absence of ligand, but reductions in the level of the endogenous AHR protein pool shifted the dose-response curve for TCDD to the right."( Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation.
Pollenz, RS; Song, Z, 2002
)
0.31
" In addition, the plasma area under the curve (AUC) and the half-life of these compounds was greater following cassette dosing at 5 mg/kg compared to single administration at the same dose."( Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Hayes, A; Nutley, BP; Raynaud, FI; Smith, NF; Workman, P, 2004
)
0.32
"Whilst cassette dosing has advantages for use in drug discovery, it is probably unsuitable to evaluate the pharmacokinetics of geldanamycin analogues due to non-linear pharmacokinetics and drug-drug interaction."( Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Hayes, A; Nutley, BP; Raynaud, FI; Smith, NF; Workman, P, 2004
)
0.32
" In summary, these results suggest that dosage will be a critical factor in the treatment of tumor patients with HSP90 inhibitors."( Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
Franke, C; Hahn, T; Ibrahim, NO; Katschinski, DM; Stiehl, DP; Wenger, RH; Wirthner, R, 2005
)
0.33
" Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clinical studies."( BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
Boehm, MF; Brekken, J; Burrows, FJ; Busch, DJ; Friedman, J; Hong, K; Huser, N; Kamal, A; Kasibhatla, SR; Lundgren, K; McKenzie, A; Neely, L; Powell, RE; Scannevin, R; Sensintaffar, JL; Timple, N; Yang, YC; Zhang, H, 2009
)
0.35
" Chronic dosing with HSP90 inhibitors reversed hyperglycemia in the diabetic db/db mouse model, and improved insulin sensitivity in the diet-induced obese mouse model of insulin resistance, further supporting the concept that the HSF1 pathway is a potentially viable anti-diabetes target."( Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice.
Elliman, SJ; Gao, J; Gromada, J; Hughes, TE; Kemp, DM; Kosinski, PA; Lee, JH, 2013
)
0.39
" Specifically, dosed intraperitoneally at 100 mg/kg, 17-(allylamino)-17-demethoxygeldanamycin and other 17-amino analogs were effective at reducing p185 phosphotyrosine in subcutaneous flank FRE/erbB-2 tumors."( Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
Barbacci, EG; Cooper, BA; Corman, ML; Dee, MF; DiOrio, CI; Doty, JL; Gallaschun, RJ; Moyer, JD; Muzzi, ML; Schnur, RC, 1995
)
0.29
" We wish to disclose the discovery of a macrocycle which showed impressive biomarker activity 24-h post dosing and which demonstrated prolonged exposure in tumors."( Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
Bloom, JD; Boschelli, F; Dushin, RG; Golas, JM; Johnson, M; Levin, JI; Li, Z; Liu, H; Lucas, J; Nikitenko, A; Nittoli, T; Olland, A; Otteng, M; Vogan, E; Zapf, CW, 2011
)
0.37
" Moreover, CETSA melt and ITDRFCETSA (isothermal dose-response fingerprint) curves confirmed that B7 bound to Hsp90α in 293T cells."( Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors.
Hao, H; Li, Z; Liang, C; Lu, C; Shen, Y; Wu, X; Zhu, J, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
antiviral agentA substance that destroys or inhibits replication of viruses.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
cysteine protease inhibitorAny protease inhibitor that restricts the action of a cysteine protease.
Hsp90 inhibitorAn EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor that blocks the action of heat shock protein 90.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
ansamycinA class of macrocyclic lactams that consist of an aromatic (phenyl or naphthyl) or quinonoid (benzoquinone or naphthoquinone) moiety that is bridged by an aliphatic chain.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
organic heterobicyclic compound
1,4-benzoquinonesAny member of the class of benzoquinones that is 1,4-benzoquinone or its C-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency3.53970.140911.194039.8107AID2451
ATAD5 protein, partialHomo sapiens (human)Potency8.03300.004110.890331.5287AID624248; AID624249; AID624250; AID624251; AID624252
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency35.48130.016525.307841.3999AID602332
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency79.43280.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency4.46680.00798.23321,122.0200AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Lysine-specific demethylase 6BHomo sapiens (human)IC50 (µMol)0.40000.01601.66726.9000AID1885317
Lysine-specific demethylase 4BHomo sapiens (human)IC50 (µMol)0.70000.20001.22003.8000AID1885314
Tyrosine-protein kinase ABL1Homo sapiens (human)IC50 (µMol)3.00000.00010.712810.0000AID1625306; AID1625307
ATP-dependent molecular chaperone HSP82Saccharomyces cerevisiae S288CIC50 (µMol)3.96670.03004.38148.9000AID240503; AID430854
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)0.01400.00011.774010.0000AID1338351
Heat shock protein HSP 90-alphaHomo sapiens (human)IC50 (µMol)0.09170.00040.695010.0000AID103418; AID1141019; AID1167274; AID1187079; AID1338351; AID1390961; AID1390964; AID1401931; AID1625290; AID1627905; AID1627906; AID1627907; AID1627908; AID1627909; AID1659865; AID312949; AID591312; AID598611; AID608899; AID767754
Heat shock protein HSP 90-betaHomo sapiens (human)IC50 (µMol)0.09800.00100.683610.0000AID103418; AID1181926; AID1390961; AID1625290; AID395908; AID708844; AID767753
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)0.01400.00011.753610.0000AID1338351
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)0.01400.00002.015110.0000AID1401931
Breakpoint cluster region proteinHomo sapiens (human)IC50 (µMol)3.00000.00030.620010.0000AID1625306; AID1625307
Heat shock protein HSP 90Oryctolagus cuniculus (rabbit)IC50 (µMol)1.14100.28201.14102.0000AID1181925; AID595269
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)0.07400.00002.800510.0000AID1141019
Cytochrome P450 3A5Homo sapiens (human)IC50 (µMol)0.01400.00330.70736.2000AID1338351
Cytochrome P450 3A7Homo sapiens (human)IC50 (µMol)0.01400.01402.75806.2000AID1338351
Lysine-specific demethylase 5AHomo sapiens (human)IC50 (µMol)0.13000.13002.374710.0000AID1885316
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)0.07400.00002.398310.0000AID1141019
EndoplasminCanis lupus familiaris (dog)IC50 (µMol)0.01000.01000.14820.5780AID767752
Heat shock protein 75 kDa, mitochondrialHomo sapiens (human)IC50 (µMol)0.66100.03770.49511.5860AID767751
Putative heat shock protein HSP 90-alpha A4Homo sapiens (human)IC50 (µMol)0.14000.14000.46000.7800AID1801076
Lysine-specific demethylase 4CHomo sapiens (human)IC50 (µMol)0.70000.16002.11489.4000AID1885315
Cytochrome P450 3A43 Homo sapiens (human)IC50 (µMol)0.01400.01402.75806.2000AID1338351
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-dependent molecular chaperone HSP82Saccharomyces cerevisiae S288CKd1.20000.01900.60951.2000AID395890
Heat shock protein HSP 90-alphaHomo sapiens (human)EC50 (µMol)0.03500.00400.13311.2000AID267820
Heat shock protein HSP 90-alphaHomo sapiens (human)Kd1.02080.00030.94889.8000AID1128881; AID1525526; AID87628; AID87629; AID87630
Heat shock protein HSP 90-betaHomo sapiens (human)EC50 (µMol)0.03500.00400.23851.7000AID267820
Heat shock protein HSP 90-betaHomo sapiens (human)Kd0.73000.00031.33309.8000AID1128880; AID1525526; AID1631712; AID350568; AID633096; AID87628
Heat shock protein 90, putativePlasmodium falciparum 3D7Kd0.24350.16900.24350.3180AID1128879; AID1631711
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Heat shock protein HSP 90-alphaHomo sapiens (human)Concentration5.00005.00005.00005.0000AID244290
Heat shock protein HSP 90-betaHomo sapiens (human)Activity0.16550.05000.53371.2700AID465290; AID465291
Tissue factorHomo sapiens (human)Concentration5.00005.00005.00005.0000AID244290
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (276)

Processvia Protein(s)Taxonomy
inflammatory response to antigenic stimulusLysine-specific demethylase 6BHomo sapiens (human)
chromatin remodelingLysine-specific demethylase 6BHomo sapiens (human)
response to activityLysine-specific demethylase 6BHomo sapiens (human)
hippocampus developmentLysine-specific demethylase 6BHomo sapiens (human)
cell fate commitmentLysine-specific demethylase 6BHomo sapiens (human)
endothelial cell differentiationLysine-specific demethylase 6BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IILysine-specific demethylase 6BHomo sapiens (human)
mesodermal cell differentiationLysine-specific demethylase 6BHomo sapiens (human)
cardiac muscle cell differentiationLysine-specific demethylase 6BHomo sapiens (human)
response to fungicideLysine-specific demethylase 6BHomo sapiens (human)
cellular response to hydrogen peroxideLysine-specific demethylase 6BHomo sapiens (human)
positive regulation of cold-induced thermogenesisLysine-specific demethylase 6BHomo sapiens (human)
heart developmentLysine-specific demethylase 6BHomo sapiens (human)
regulation of gene expressionLysine-specific demethylase 6BHomo sapiens (human)
brain developmentLysine-specific demethylase 4BHomo sapiens (human)
chromatin remodelingLysine-specific demethylase 4BHomo sapiens (human)
regulation of gene expressionLysine-specific demethylase 4BHomo sapiens (human)
response to oxidative stressTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activityTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of phospholipase C activityTyrosine-protein kinase ABL1Homo sapiens (human)
mitotic cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
neural tube closureTyrosine-protein kinase ABL1Homo sapiens (human)
B-1 B cell homeostasisTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of protein phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
B cell proliferation involved in immune responseTyrosine-protein kinase ABL1Homo sapiens (human)
transitional one stage B cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
mismatch repairTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of DNA-templated transcriptionTyrosine-protein kinase ABL1Homo sapiens (human)
autophagyTyrosine-protein kinase ABL1Homo sapiens (human)
DNA damage responseTyrosine-protein kinase ABL1Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
canonical NF-kappaB signal transductionTyrosine-protein kinase ABL1Homo sapiens (human)
associative learningTyrosine-protein kinase ABL1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageTyrosine-protein kinase ABL1Homo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase ABL1Homo sapiens (human)
post-embryonic developmentTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of autophagyTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of endothelial cell migrationTyrosine-protein kinase ABL1Homo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
cerebellum morphogenesisTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of cell-cell adhesionTyrosine-protein kinase ABL1Homo sapiens (human)
microspike assemblyTyrosine-protein kinase ABL1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein kinase ABL1Homo sapiens (human)
actin filament polymerizationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of endocytosisTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of cell adhesionTyrosine-protein kinase ABL1Homo sapiens (human)
neuron differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
BMP signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of BMP signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of axon extensionTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of microtubule polymerizationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of Cdc42 protein signal transductionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of type II interferon productionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of interleukin-2 productionTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of actin cytoskeleton organizationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of osteoblast proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
substrate adhesion-dependent cell spreadingTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to oxidative stressTyrosine-protein kinase ABL1Homo sapiens (human)
response to endoplasmic reticulum stressTyrosine-protein kinase ABL1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
protein modification processTyrosine-protein kinase ABL1Homo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisTyrosine-protein kinase ABL1Homo sapiens (human)
neuropilin signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
signal transduction in response to DNA damageTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of neuron apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
endothelial cell migrationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of T cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of vasoconstrictionTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of mitotic cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITyrosine-protein kinase ABL1Homo sapiens (human)
alpha-beta T cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
protein autophosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of fibroblast proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
spleen developmentTyrosine-protein kinase ABL1Homo sapiens (human)
thymus developmentTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
activated T cell proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
neuromuscular process controlling balanceTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of oxidoreductase activityTyrosine-protein kinase ABL1Homo sapiens (human)
neuron apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activityTyrosine-protein kinase ABL1Homo sapiens (human)
myoblast proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of stress fiber assemblyTyrosine-protein kinase ABL1Homo sapiens (human)
establishment of localization in cellTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
mitochondrial depolarizationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of focal adhesion assemblyTyrosine-protein kinase ABL1Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
cardiac muscle cell proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
neuroepithelial cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to hydrogen peroxideTyrosine-protein kinase ABL1Homo sapiens (human)
ERK1 and ERK2 cascadeTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein kinase ABL1Homo sapiens (human)
DNA conformation changeTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to lipopolysaccharideTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to transforming growth factor beta stimulusTyrosine-protein kinase ABL1Homo sapiens (human)
response to epinephrineTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of protein serine/threonine kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisTyrosine-protein kinase ABL1Homo sapiens (human)
cellular senescenceTyrosine-protein kinase ABL1Homo sapiens (human)
cell-cell adhesionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of dendrite developmentTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of long-term synaptic potentiationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of hematopoietic stem cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of extracellular matrix organizationTyrosine-protein kinase ABL1Homo sapiens (human)
podocyte apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to dopamineTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of establishment of T cell polarityTyrosine-protein kinase ABL1Homo sapiens (human)
DN4 thymocyte differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
protein localization to cytoplasmic microtubule plus-endTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of microtubule bindingTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of actin filament bindingTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of modification of synaptic structureTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of blood vessel branchingTyrosine-protein kinase ABL1Homo sapiens (human)
activation of protein kinase C activityTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of Wnt signaling pathway, planar cell polarity pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of cell motilityTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of endothelial cell apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of T cell migrationTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of cellular senescenceTyrosine-protein kinase ABL1Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
telomere maintenance via telomeraseHeat shock protein HSP 90-alphaHomo sapiens (human)
neuron migrationHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein phosphorylationHeat shock protein HSP 90-alphaHomo sapiens (human)
activation of innate immune responseHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of defense response to virus by hostHeat shock protein HSP 90-alphaHomo sapiens (human)
skeletal muscle contractionHeat shock protein HSP 90-alphaHomo sapiens (human)
mitochondrial transportHeat shock protein HSP 90-alphaHomo sapiens (human)
response to unfolded proteinHeat shock protein HSP 90-alphaHomo sapiens (human)
response to heatHeat shock protein HSP 90-alphaHomo sapiens (human)
response to coldHeat shock protein HSP 90-alphaHomo sapiens (human)
response to xenobiotic stimulusHeat shock protein HSP 90-alphaHomo sapiens (human)
response to salt stressHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of lamellipodium assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
cardiac muscle cell apoptotic processHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of protein ubiquitinationHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein polymerizationHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of interferon-beta productionHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of protein localizationHeat shock protein HSP 90-alphaHomo sapiens (human)
protein refoldingHeat shock protein HSP 90-alphaHomo sapiens (human)
response to cocaineHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein import into nucleusHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of apoptotic processHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of protein-containing complex assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
protein unfoldingHeat shock protein HSP 90-alphaHomo sapiens (human)
response to estrogenHeat shock protein HSP 90-alphaHomo sapiens (human)
protein insertion into mitochondrial outer membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein catabolic processHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of cell sizeHeat shock protein HSP 90-alphaHomo sapiens (human)
response to antibioticHeat shock protein HSP 90-alphaHomo sapiens (human)
protein stabilizationHeat shock protein HSP 90-alphaHomo sapiens (human)
chaperone-mediated protein complex assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of cardiac muscle contractionHeat shock protein HSP 90-alphaHomo sapiens (human)
chaperone-mediated autophagyHeat shock protein HSP 90-alphaHomo sapiens (human)
cellular response to virusHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of postsynaptic membrane neurotransmitter receptor levelsHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of tau-protein kinase activityHeat shock protein HSP 90-alphaHomo sapiens (human)
telomerase holoenzyme complex assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
cellular response to heatHeat shock protein HSP 90-alphaHomo sapiens (human)
protein foldingHeat shock protein HSP 90-alphaHomo sapiens (human)
telomere maintenance via telomeraseHeat shock protein HSP 90-betaHomo sapiens (human)
placenta developmentHeat shock protein HSP 90-betaHomo sapiens (human)
response to unfolded proteinHeat shock protein HSP 90-betaHomo sapiens (human)
virion attachment to host cellHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of protein ubiquitinationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of phosphoprotein phosphatase activityHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of protein localizationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of apoptotic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of cell differentiationHeat shock protein HSP 90-betaHomo sapiens (human)
chaperone-mediated protein complex assemblyHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of cell cycleHeat shock protein HSP 90-betaHomo sapiens (human)
chaperone-mediated protein foldingHeat shock protein HSP 90-betaHomo sapiens (human)
cellular response to interleukin-4Heat shock protein HSP 90-betaHomo sapiens (human)
supramolecular fiber organizationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of proteasomal protein catabolic processHeat shock protein HSP 90-betaHomo sapiens (human)
telomerase holoenzyme complex assemblyHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of protein localization to cell surfaceHeat shock protein HSP 90-betaHomo sapiens (human)
cellular response to heatHeat shock protein HSP 90-betaHomo sapiens (human)
protein foldingHeat shock protein HSP 90-betaHomo sapiens (human)
protein stabilizationHeat shock protein HSP 90-betaHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular extravasationBreakpoint cluster region proteinHomo sapiens (human)
renal system processBreakpoint cluster region proteinHomo sapiens (human)
protein phosphorylationBreakpoint cluster region proteinHomo sapiens (human)
phagocytosisBreakpoint cluster region proteinHomo sapiens (human)
signal transductionBreakpoint cluster region proteinHomo sapiens (human)
small GTPase-mediated signal transductionBreakpoint cluster region proteinHomo sapiens (human)
brain developmentBreakpoint cluster region proteinHomo sapiens (human)
actin cytoskeleton organizationBreakpoint cluster region proteinHomo sapiens (human)
keratinocyte differentiationBreakpoint cluster region proteinHomo sapiens (human)
regulation of Rho protein signal transductionBreakpoint cluster region proteinHomo sapiens (human)
inner ear morphogenesisBreakpoint cluster region proteinHomo sapiens (human)
regulation of vascular permeabilityBreakpoint cluster region proteinHomo sapiens (human)
neutrophil degranulationBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of neutrophil degranulationBreakpoint cluster region proteinHomo sapiens (human)
focal adhesion assemblyBreakpoint cluster region proteinHomo sapiens (human)
homeostasis of number of cellsBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of inflammatory responseBreakpoint cluster region proteinHomo sapiens (human)
positive regulation of phagocytosisBreakpoint cluster region proteinHomo sapiens (human)
modulation of chemical synaptic transmissionBreakpoint cluster region proteinHomo sapiens (human)
neuromuscular process controlling balanceBreakpoint cluster region proteinHomo sapiens (human)
regulation of small GTPase mediated signal transductionBreakpoint cluster region proteinHomo sapiens (human)
regulation of cell cycleBreakpoint cluster region proteinHomo sapiens (human)
definitive hemopoiesisBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of respiratory burstBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of blood vessel remodelingBreakpoint cluster region proteinHomo sapiens (human)
intracellular protein transmembrane transportBreakpoint cluster region proteinHomo sapiens (human)
cellular response to lipopolysaccharideBreakpoint cluster region proteinHomo sapiens (human)
activation of GTPase activityBreakpoint cluster region proteinHomo sapiens (human)
macrophage migrationBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of macrophage migrationBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processBreakpoint cluster region proteinHomo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
positive regulation of gene expressionTissue factorHomo sapiens (human)
positive regulation of interleukin-8 productionTissue factorHomo sapiens (human)
positive regulation of endothelial cell proliferationTissue factorHomo sapiens (human)
activation of plasma proteins involved in acute inflammatory responseTissue factorHomo sapiens (human)
activation of blood coagulation via clotting cascadeTissue factorHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTissue factorHomo sapiens (human)
blood coagulationTissue factorHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor signaling pathwayTissue factorHomo sapiens (human)
protein processingTissue factorHomo sapiens (human)
positive regulation of cell migrationTissue factorHomo sapiens (human)
positive regulation of TOR signalingTissue factorHomo sapiens (human)
positive regulation of angiogenesisTissue factorHomo sapiens (human)
positive regulation of positive chemotaxisTissue factorHomo sapiens (human)
cytokine-mediated signaling pathwayTissue factorHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A5Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A5Homo sapiens (human)
steroid metabolic processCytochrome P450 3A5Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A5Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A5Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A5Homo sapiens (human)
retinol metabolic processCytochrome P450 3A5Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A5Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A5Homo sapiens (human)
oxidative demethylationCytochrome P450 3A5Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A7Homo sapiens (human)
steroid biosynthetic processCytochrome P450 3A7Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A7Homo sapiens (human)
steroid metabolic processCytochrome P450 3A7Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A7Homo sapiens (human)
retinol metabolic processCytochrome P450 3A7Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A7Homo sapiens (human)
oxidative demethylationCytochrome P450 3A7Homo sapiens (human)
negative regulation of transcription by RNA polymerase IILysine-specific demethylase 5AHomo sapiens (human)
circadian regulation of gene expressionLysine-specific demethylase 5AHomo sapiens (human)
positive regulation of DNA-templated transcriptionLysine-specific demethylase 5AHomo sapiens (human)
regulation of DNA-binding transcription factor activityLysine-specific demethylase 5AHomo sapiens (human)
facultative heterochromatin formationLysine-specific demethylase 5AHomo sapiens (human)
regulation of DNA-templated transcriptionLysine-specific demethylase 5AHomo sapiens (human)
chromatin remodelingLysine-specific demethylase 5AHomo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
ERAD pathwayEndoplasminCanis lupus familiaris (dog)
translational attenuationHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
chaperone-mediated protein foldingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
negative regulation of cellular respirationHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxideHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
protein foldingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
biological_processPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
protein stabilizationPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
cellular response to heatPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
protein foldingPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
blastocyst formationLysine-specific demethylase 4CHomo sapiens (human)
positive regulation of cell population proliferationLysine-specific demethylase 4CHomo sapiens (human)
stem cell population maintenanceLysine-specific demethylase 4CHomo sapiens (human)
androgen receptor signaling pathwayLysine-specific demethylase 4CHomo sapiens (human)
positive regulation of transcription by RNA polymerase IILysine-specific demethylase 4CHomo sapiens (human)
regulation of androgen receptor signaling pathwayLysine-specific demethylase 4CHomo sapiens (human)
regulation of stem cell differentiationLysine-specific demethylase 4CHomo sapiens (human)
regulation of gene expressionLysine-specific demethylase 4CHomo sapiens (human)
chromatin remodelingLysine-specific demethylase 4CHomo sapiens (human)
cytochrome metabolic processCytochrome P450 3A43 Homo sapiens (human)
steroid metabolic processCytochrome P450 3A43 Homo sapiens (human)
oxidative demethylationCytochrome P450 3A43 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (127)

Processvia Protein(s)Taxonomy
protein bindingLysine-specific demethylase 6BHomo sapiens (human)
beta-catenin bindingLysine-specific demethylase 6BHomo sapiens (human)
histone demethylase activityLysine-specific demethylase 6BHomo sapiens (human)
metal ion bindingLysine-specific demethylase 6BHomo sapiens (human)
histone H3K27me2/H3K27me3 demethylase activityLysine-specific demethylase 6BHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingLysine-specific demethylase 6BHomo sapiens (human)
chromatin DNA bindingLysine-specific demethylase 6BHomo sapiens (human)
histone demethylase activityLysine-specific demethylase 4BHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific demethylase 4BHomo sapiens (human)
metal ion bindingLysine-specific demethylase 4BHomo sapiens (human)
histone H3K36 demethylase activityLysine-specific demethylase 4BHomo sapiens (human)
histone H3K9me2/H3K9me3 demethylase activityLysine-specific demethylase 4BHomo sapiens (human)
supercoiled DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
magnesium ion bindingTyrosine-protein kinase ABL1Homo sapiens (human)
four-way junction DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
bubble DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase ABL1Homo sapiens (human)
DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
transcription coactivator activityTyrosine-protein kinase ABL1Homo sapiens (human)
actin monomer bindingTyrosine-protein kinase ABL1Homo sapiens (human)
nicotinate-nucleotide adenylyltransferase activityTyrosine-protein kinase ABL1Homo sapiens (human)
protein kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
protein kinase C bindingTyrosine-protein kinase ABL1Homo sapiens (human)
protein bindingTyrosine-protein kinase ABL1Homo sapiens (human)
ATP bindingTyrosine-protein kinase ABL1Homo sapiens (human)
kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
SH3 domain bindingTyrosine-protein kinase ABL1Homo sapiens (human)
syntaxin bindingTyrosine-protein kinase ABL1Homo sapiens (human)
manganese ion bindingTyrosine-protein kinase ABL1Homo sapiens (human)
neuropilin bindingTyrosine-protein kinase ABL1Homo sapiens (human)
SH2 domain bindingTyrosine-protein kinase ABL1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein kinase ABL1Homo sapiens (human)
actin filament bindingTyrosine-protein kinase ABL1Homo sapiens (human)
mitogen-activated protein kinase bindingTyrosine-protein kinase ABL1Homo sapiens (human)
proline-rich region bindingTyrosine-protein kinase ABL1Homo sapiens (human)
delta-catenin bindingTyrosine-protein kinase ABL1Homo sapiens (human)
sequence-specific double-stranded DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
UTP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
CTP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
RNA bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
mRNA bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ATP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
GTP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ATP hydrolysis activityHeat shock protein HSP 90-alphaHomo sapiens (human)
sulfonylurea receptor bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
protein phosphatase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
MHC class II protein complex bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
nitric-oxide synthase regulator activityHeat shock protein HSP 90-alphaHomo sapiens (human)
TPR domain bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ubiquitin protein ligase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
dATP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
identical protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
protein homodimerization activityHeat shock protein HSP 90-alphaHomo sapiens (human)
histone deacetylase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
transmembrane transporter bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
tau protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
GTPase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
Rho GDP-dissociation inhibitor bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
DNA polymerase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
scaffold protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
disordered domain specific bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock protein HSP 90-alphaHomo sapiens (human)
protein tyrosine kinase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
unfolded protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
RNA bindingHeat shock protein HSP 90-betaHomo sapiens (human)
double-stranded RNA bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP hydrolysis activityHeat shock protein HSP 90-betaHomo sapiens (human)
protein kinase regulator activityHeat shock protein HSP 90-betaHomo sapiens (human)
kinase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein kinase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
MHC class II protein complex bindingHeat shock protein HSP 90-betaHomo sapiens (human)
nitric-oxide synthase regulator activityHeat shock protein HSP 90-betaHomo sapiens (human)
TPR domain bindingHeat shock protein HSP 90-betaHomo sapiens (human)
heat shock protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ubiquitin protein ligase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
peptide bindingHeat shock protein HSP 90-betaHomo sapiens (human)
identical protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein homodimerization activityHeat shock protein HSP 90-betaHomo sapiens (human)
histone deacetylase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP-dependent protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein folding chaperoneHeat shock protein HSP 90-betaHomo sapiens (human)
cadherin bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein dimerization activityHeat shock protein HSP 90-betaHomo sapiens (human)
tau protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
DNA polymerase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
disordered domain specific bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock protein HSP 90-betaHomo sapiens (human)
receptor ligand inhibitor activityHeat shock protein HSP 90-betaHomo sapiens (human)
histone methyltransferase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
unfolded protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
protein serine/threonine kinase activityBreakpoint cluster region proteinHomo sapiens (human)
protein tyrosine kinase activityBreakpoint cluster region proteinHomo sapiens (human)
guanyl-nucleotide exchange factor activityBreakpoint cluster region proteinHomo sapiens (human)
GTPase activator activityBreakpoint cluster region proteinHomo sapiens (human)
protein bindingBreakpoint cluster region proteinHomo sapiens (human)
ATP bindingBreakpoint cluster region proteinHomo sapiens (human)
protein serine kinase activityBreakpoint cluster region proteinHomo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
serine-type endopeptidase activityTissue factorHomo sapiens (human)
protease bindingTissue factorHomo sapiens (human)
protein bindingTissue factorHomo sapiens (human)
phospholipid bindingTissue factorHomo sapiens (human)
cytokine receptor activityTissue factorHomo sapiens (human)
monooxygenase activityCytochrome P450 3A5Homo sapiens (human)
iron ion bindingCytochrome P450 3A5Homo sapiens (human)
protein bindingCytochrome P450 3A5Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A5Homo sapiens (human)
oxygen bindingCytochrome P450 3A5Homo sapiens (human)
heme bindingCytochrome P450 3A5Homo sapiens (human)
aromatase activityCytochrome P450 3A5Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
monooxygenase activityCytochrome P450 3A7Homo sapiens (human)
iron ion bindingCytochrome P450 3A7Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
oxygen bindingCytochrome P450 3A7Homo sapiens (human)
heme bindingCytochrome P450 3A7Homo sapiens (human)
all-trans retinoic acid 18-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
aromatase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
transcription cis-regulatory region bindingLysine-specific demethylase 5AHomo sapiens (human)
DNA bindingLysine-specific demethylase 5AHomo sapiens (human)
transcription coactivator activityLysine-specific demethylase 5AHomo sapiens (human)
enzyme inhibitor activityLysine-specific demethylase 5AHomo sapiens (human)
protein bindingLysine-specific demethylase 5AHomo sapiens (human)
zinc ion bindingLysine-specific demethylase 5AHomo sapiens (human)
chromatin DNA bindingLysine-specific demethylase 5AHomo sapiens (human)
histone demethylase activityLysine-specific demethylase 5AHomo sapiens (human)
histone H3K4me/H3K4me2/H3K4me3 demethylase activityLysine-specific demethylase 5AHomo sapiens (human)
methylated histone bindingLysine-specific demethylase 5AHomo sapiens (human)
histone bindingLysine-specific demethylase 5AHomo sapiens (human)
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
ATP bindingEndoplasminCanis lupus familiaris (dog)
ATP hydrolysis activityEndoplasminCanis lupus familiaris (dog)
ATP-dependent protein folding chaperoneEndoplasminCanis lupus familiaris (dog)
RNA bindingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
tumor necrosis factor receptor bindingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
protein bindingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
ATP bindingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
ATP hydrolysis activityHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
protein kinase bindingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
unfolded protein bindingHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
molecular_functionPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
ATP hydrolysis activityPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
ATP-dependent protein folding chaperonePutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
disordered domain specific bindingPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
unfolded protein bindingPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
ATP bindingPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
histone H3K9me2/H3K9me3 demethylase activityLysine-specific demethylase 4CHomo sapiens (human)
zinc ion bindingLysine-specific demethylase 4CHomo sapiens (human)
enzyme bindingLysine-specific demethylase 4CHomo sapiens (human)
nuclear receptor coactivator activityLysine-specific demethylase 4CHomo sapiens (human)
histone demethylase activityLysine-specific demethylase 4CHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific demethylase 4CHomo sapiens (human)
nuclear androgen receptor bindingLysine-specific demethylase 4CHomo sapiens (human)
histone H3K36 demethylase activityLysine-specific demethylase 4CHomo sapiens (human)
H3K9me3 modified histone bindingLysine-specific demethylase 4CHomo sapiens (human)
histone H3K9me2/H3K9me3 demethylase activityLysine-specific demethylase 4CHomo sapiens (human)
monooxygenase activityCytochrome P450 3A43 Homo sapiens (human)
iron ion bindingCytochrome P450 3A43 Homo sapiens (human)
heme bindingCytochrome P450 3A43 Homo sapiens (human)
aromatase activityCytochrome P450 3A43 Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A43 Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A43 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (60)

Processvia Protein(s)Taxonomy
nucleusLysine-specific demethylase 6BHomo sapiens (human)
nucleoplasmLysine-specific demethylase 6BHomo sapiens (human)
MLL3/4 complexLysine-specific demethylase 6BHomo sapiens (human)
nucleoplasmLysine-specific demethylase 4BHomo sapiens (human)
chromatinLysine-specific demethylase 4BHomo sapiens (human)
nucleusLysine-specific demethylase 4BHomo sapiens (human)
ruffleTyrosine-protein kinase ABL1Homo sapiens (human)
nucleusTyrosine-protein kinase ABL1Homo sapiens (human)
nucleoplasmTyrosine-protein kinase ABL1Homo sapiens (human)
nucleolusTyrosine-protein kinase ABL1Homo sapiens (human)
cytoplasmTyrosine-protein kinase ABL1Homo sapiens (human)
mitochondrionTyrosine-protein kinase ABL1Homo sapiens (human)
cytosolTyrosine-protein kinase ABL1Homo sapiens (human)
actin cytoskeletonTyrosine-protein kinase ABL1Homo sapiens (human)
nuclear bodyTyrosine-protein kinase ABL1Homo sapiens (human)
dendriteTyrosine-protein kinase ABL1Homo sapiens (human)
growth coneTyrosine-protein kinase ABL1Homo sapiens (human)
nuclear membraneTyrosine-protein kinase ABL1Homo sapiens (human)
neuronal cell bodyTyrosine-protein kinase ABL1Homo sapiens (human)
perinuclear region of cytoplasmTyrosine-protein kinase ABL1Homo sapiens (human)
postsynapseTyrosine-protein kinase ABL1Homo sapiens (human)
protein-containing complexTyrosine-protein kinase ABL1Homo sapiens (human)
plasma membraneTyrosine-protein kinase ABL1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
extracellular regionHeat shock protein HSP 90-alphaHomo sapiens (human)
nucleusHeat shock protein HSP 90-alphaHomo sapiens (human)
nucleoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
cytoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
mitochondrionHeat shock protein HSP 90-alphaHomo sapiens (human)
cytosolHeat shock protein HSP 90-alphaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
cell surfaceHeat shock protein HSP 90-alphaHomo sapiens (human)
membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
basolateral plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
apical plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
brush border membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
secretory granule lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
melanosomeHeat shock protein HSP 90-alphaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-alphaHomo sapiens (human)
lysosomal lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
dendritic growth coneHeat shock protein HSP 90-alphaHomo sapiens (human)
axonal growth coneHeat shock protein HSP 90-alphaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
collagen-containing extracellular matrixHeat shock protein HSP 90-alphaHomo sapiens (human)
extracellular exosomeHeat shock protein HSP 90-alphaHomo sapiens (human)
endocytic vesicle lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
sperm mitochondrial sheathHeat shock protein HSP 90-alphaHomo sapiens (human)
sperm plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
ficolin-1-rich granule lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
protein-containing complexHeat shock protein HSP 90-alphaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-alphaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
myelin sheathHeat shock protein HSP 90-alphaHomo sapiens (human)
cytosolHeat shock protein HSP 90-alphaHomo sapiens (human)
nucleusHeat shock protein HSP 90-alphaHomo sapiens (human)
COP9 signalosomeHeat shock protein HSP 90-betaHomo sapiens (human)
protein folding chaperone complexHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular regionHeat shock protein HSP 90-betaHomo sapiens (human)
nucleusHeat shock protein HSP 90-betaHomo sapiens (human)
nucleoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
mitochondrionHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolHeat shock protein HSP 90-betaHomo sapiens (human)
cell surfaceHeat shock protein HSP 90-betaHomo sapiens (human)
membraneHeat shock protein HSP 90-betaHomo sapiens (human)
secretory granule lumenHeat shock protein HSP 90-betaHomo sapiens (human)
melanosomeHeat shock protein HSP 90-betaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-betaHomo sapiens (human)
dendritic growth coneHeat shock protein HSP 90-betaHomo sapiens (human)
axonal growth coneHeat shock protein HSP 90-betaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular exosomeHeat shock protein HSP 90-betaHomo sapiens (human)
dynein axonemal particleHeat shock protein HSP 90-betaHomo sapiens (human)
ficolin-1-rich granule lumenHeat shock protein HSP 90-betaHomo sapiens (human)
protein-containing complexHeat shock protein HSP 90-betaHomo sapiens (human)
aryl hydrocarbon receptor complexHeat shock protein HSP 90-betaHomo sapiens (human)
HSP90-CDC37 chaperone complexHeat shock protein HSP 90-betaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolHeat shock protein HSP 90-betaHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
cytosolBreakpoint cluster region proteinHomo sapiens (human)
plasma membraneBreakpoint cluster region proteinHomo sapiens (human)
postsynaptic densityBreakpoint cluster region proteinHomo sapiens (human)
membraneBreakpoint cluster region proteinHomo sapiens (human)
axonBreakpoint cluster region proteinHomo sapiens (human)
dendritic spineBreakpoint cluster region proteinHomo sapiens (human)
extracellular exosomeBreakpoint cluster region proteinHomo sapiens (human)
protein-containing complexBreakpoint cluster region proteinHomo sapiens (human)
Schaffer collateral - CA1 synapseBreakpoint cluster region proteinHomo sapiens (human)
glutamatergic synapseBreakpoint cluster region proteinHomo sapiens (human)
membraneBreakpoint cluster region proteinHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
extracellular spaceTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
external side of plasma membraneTissue factorHomo sapiens (human)
cell surfaceTissue factorHomo sapiens (human)
membraneTissue factorHomo sapiens (human)
collagen-containing extracellular matrixTissue factorHomo sapiens (human)
serine-type peptidase complexTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A5Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A5Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A7Homo sapiens (human)
nucleusLysine-specific demethylase 5AHomo sapiens (human)
nucleoplasmLysine-specific demethylase 5AHomo sapiens (human)
nucleolusLysine-specific demethylase 5AHomo sapiens (human)
nucleusLysine-specific demethylase 5AHomo sapiens (human)
chromatinLysine-specific demethylase 5AHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
sarcoplasmic reticulum lumenEndoplasminCanis lupus familiaris (dog)
melanosomeEndoplasminCanis lupus familiaris (dog)
nucleoplasmHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
mitochondrionHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
mitochondrial inner membraneHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
mitochondrial intermembrane spaceHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
mitochondrial matrixHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
membraneHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
cell peripheryHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
mitochondrial inner membraneHeat shock protein 75 kDa, mitochondrialHomo sapiens (human)
cellular_componentPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
perinuclear region of cytoplasmPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
cytosolPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
myelin sheathPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
protein-containing complexPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
neuronal cell bodyPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
nucleusPutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
plasma membranePutative heat shock protein HSP 90-alpha A4Homo sapiens (human)
nucleoplasmLysine-specific demethylase 4CHomo sapiens (human)
chromatinLysine-specific demethylase 4CHomo sapiens (human)
pericentric heterochromatinLysine-specific demethylase 4CHomo sapiens (human)
nucleusLysine-specific demethylase 4CHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A43 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (436)

Assay IDTitleYearJournalArticle
AID567634Modulation proteolytic fingerprint of HSP90 in rabbit reticulocyte lysates assessed as formation of 40 kDa protein at 10 ug/ml after 5 mins by SDS-PAGE analysis in presence of 50 ug/ml of trypsin2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID765333Cell cycle arrest in human SKBR3 cells assessed as accumulation at subG1 phase at 0.5 uM after 48 hrs by flow cytometric analysis (Rvb = 7 +/- 1%)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1167286Cytotoxicity against human SW480 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID465291Binding affinity to HSP90 by fluorescence polarization assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Heat shock protein 90: inhibitors in clinical trials.
AID708844Inhibition of HSP90 using VER-00045864 probe by fluorescence polarization assay2012Journal of medicinal chemistry, Dec-27, Volume: 55, Issue:24
Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
AID1348004Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and pharmacological evaluation of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-N-arylmethyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamides as potent Hsp90 inhibitors.
AID347256Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID324550Increase in light chain 3-GFP+ autophagosome vesicle intensity per cell in human H4 cells at 4.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID567626Inhibition of HSP90 binding to Cdc37 in human SKBR-3 cells 10 uM by Western blotting2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID1627905Displacement of fluorescent labelled-VER00051001 from N-terminal ATP-binding site of human recombinant HSP90A expressed in Escherichia coli measured after 48 hrs by fluorescence polarization assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID1225606Inhibition of HSP90 in human MCF7 cells assessed as pAkt degradation at 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID314501Inhibition of Hsp90 in human KPL4 cells assessed as depletion of Raf-1 level after 40 hrs2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1512192Inhibition of HSP90 at N-terminus in human SKBR3 cells assessed as induction of Her2 protein degradation incubated for 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 11-15, Volume: 29, Issue:22
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
AID1268222Effect on L-aspartate biosynthesis in rat PC12 cells assessed as effect on L-aspartate level in cell culture medium up to 10 uM after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID395908Binding affinity to Hsp90 by fluorescence polarization assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery and development of heat shock protein 90 inhibitors.
AID1863186Inhibition of HDAC6 in human NCI-H1975 cells assessed as effect on alpha tubulin expression at 1 uM incubated for 24 hrs by western blot analysis2022European journal of medicinal chemistry, Oct-05, Volume: 240Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay.
AID608900Inhibition of v-Src2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
AID580560Antiviral activity against Hepatitis C virus genotype 1b Con1 infected in human HuH7 cells assessed as GAPDH RNA or 18S rRNA level after 3 days selected with 40 nM HCV-796 and 800 nM boceprevir by qRT-PCR analysis relative to control2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
AID608903Antiproliferative activity against human U87MG cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
AID1306537Anticancer activity against human MDA-MB-231 cells measured after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Design, synthesis, and anticancer activity of C8-substituted-4'-thionucleosides as potential HSP90 inhibitors.
AID392675Neuroprotection against beta-amyloid peptide 1-42-induced toxicity in retinoic acid-differentiated human SH-SY5Y cells assessed as lactate dehydrogenase release2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line.
AID1754449Inhibition of HSP90 at N-terminus in human BT-474 cells assessed as increase in cytosolic HSP90 protein level at 300 nM incubated for 24 hrs by immunostaining analysis2021Bioorganic & medicinal chemistry letters, 08-01, Volume: 45Discovery of a simplified deguelin analog as an HSP90 C-terminal inhibitor for HER2-positive breast cancer.
AID1212932Drug metabolism in human liver microsomes assessed as stability after 5 mins relative to control in presence of reduced GSH by liquid chromatography-tandem mass spectrometry2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes.
AID347248Binding affinity to human recombinant CSNK1G1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID347235Binding affinity to human recombinant PIM1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID497867Inhibition of to HSP90 in FADD deficient human Jurkat cells assessed as RIP protein degradation at 1 uM by Western blot2008Nature chemical biology, May, Volume: 4, Issue:5
Identification of RIP1 kinase as a specific cellular target of necrostatins.
AID1224750Delta TM value showing the stabilisation of CAMK1G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224789Delta TM value showing the stabilisation of PLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID633096Binding affinity to Hsp90 N-domain2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
A small molecule that preferentially binds the closed conformation of Hsp90.
AID1512190Inhibition of HSP90 at N-terminus in human SKBR3 cells assessed as induction of Raf1 protein degradation incubated for 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 11-15, Volume: 29, Issue:22
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
AID1225610Change in Cdc37 expression in human MCF7 cells at 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1224807Delta TM value showing the stabilisation of YSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1740797Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID103417Inhibition of steady-state expression of HER2 in MCF-7 breast cancer cells1999Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
Synthesis and evaluation of geldanamycin-estradiol hybrids.
AID1740798Antiproliferative activity against human PC-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID595262Inhibition of Hsp90 in human MCF7 cells assessed as Raf degradation at 0.5 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1740808Binding affinity to yeast HSP90 assessed as dissociation constant by isothermal titration calorimetry2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1650616Effect on HER2 mRNA expression in human MCF7 cells at 10 uM incubated for 24 hrs by qRT-PCR analysis2020Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
Identification of vibsanin A analog as a novel HSP90 inhibitor.
AID1224796Delta TM value showing the stabilisation of LOK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1631712Binding affinity to recombinant human Hsp90 beta expressed in Escherichia coli BL21(DE3) pLysS by microscale thermophoresis assay2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles.
AID299070Antiproliferative activity against SKBR3 cells2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity.
AID332871Acute toxicity in rat at 2500 to 5000 mg/kg, po
AID1224759Delta TM value showing the stabilisation of CDKL1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1128882Binding affinity to N-terminal FLAG-tagged Plasmodium falciparum recombinant HSP90 ISG-LGA mutant expressed in Escherichia coli BL21(DE3) by microscale thermophoresis assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
AID347243Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID324394Induction of light chain 3-GFP level in human H4 cells at 4.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1268220Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of D-aspartate level in cell culture medium up to 10 uM after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1167285Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID765348Inhibition of HSP90 in rabbit reticulocyte lysate assessed as inhibition of heat-denatured luciferase refolding at 0.5 uM by luminescence plate reader analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1224791Delta TM value showing the stabilisation of PRKACA produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224772Delta TM value showing the stabilisation of MAP2K6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1625306Inhibition of BCR-ABL (unknown origin) expressed in mouse BA/F3 cells assessed as decrease in cell viability after 48 hrs by trypan blue exclusion assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions.
AID591312Inhibition of Hsp90alpha after 3 hrs by fluorescence polarization assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.
AID430854Inhibition of yeast Hsp90 ATPase activity by ATPase assay using malachite green colorimetric method2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Identification of new Hsp90 inhibitors by structure-based virtual screening.
AID1306535Anticancer activity against human Caki1 cells measured after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Design, synthesis, and anticancer activity of C8-substituted-4'-thionucleosides as potential HSP90 inhibitors.
AID392677Neuroprotection against beta-amyloid peptide 1-42-induced toxicity in human SH-SY5Y cells assessed as lactate dehydrogenase release2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line.
AID1740809Binding affinity to HSP90 (unknown origin)2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID567628Inhibition of HSP90 in human MCF7 cells assessed as degradation of AKT protein after 48 hrs by Western blotting2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID1663552Antiproliferative activity against human SW480 cells assessed as cell growth inhibition by MTT assay2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
AID395890Binding affinity to N-terminal ATP/ADP-binding domain of yeast Hsp902009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery and development of heat shock protein 90 inhibitors.
AID1338351Inhibition of fluorescein isothiocyanate labeled geldanamycin binding to N-terminal domain of full length human recombinant Hsp90alpha expressed in Escherichia coli BL21 (DE3) after 14 hrs by fluorescence polarization assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID1225628Inhibition of HSP90 in human MCF7 cells assessed as disruption of interaction with Cdc37 at 5 times IC50 after 24 hrs by co-immunoprecipitation assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1224754Delta TM value showing the stabilisation of CAMK2G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224752Delta TM value showing the stabilisation of CAMK2B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1627904Antiproliferative activity against human A2780 assessed as reduction in cell viability measured after 96 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID324583Increase in long-lived protein degradation in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID595297Inhibition of Hsp90-dependent activation of [35S]-labeled His-tagged eIF2alpha in rabbit reticulocyte lysate at 1 ug/ml by anti-His-tag pull down assay2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1268216Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of total D-aspartate level after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1740799Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID595263Inhibition of Hsp90 in human MCF7 cells assessed as Hsp90 degradation at 0.5 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1401932Antiproliferative activity against human SKBR3 cells after 72 hrs by Cell Titer 96 Aqueous One Solution cell proliferation assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of a series of resorcinol-based N-benzyl benzamide derivatives as potent Hsp90 inhibitors.
AID1181931Displacement of FITC-geldanamycin from human HSP90 at 0.001 to 10000 nM by fluorescence polarization assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
AID267820Displacement of GM-BODIPY from Hsp902006Bioorganic & medicinal chemistry letters, Jul-01, Volume: 16, Issue:13
Synthesis of Hsp90 dimerization modulators.
AID1751339Cytotoxicity against human MGC-803 cells
AID1659868Cytotoxicity against human HL60 cells assessed as reduction in cell viability2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID347238Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID598615Inhibition of CYP2C9 at 3 uM2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID444540Antiproliferative activity against human SK-BR-3 cells2009Bioorganic & medicinal chemistry letters, Dec-15, Volume: 19, Issue:24
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors.
AID1885316Inhibition of KDM5A (unknown origin) measured by AlphaScreen assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Recent Advances with KDM4 Inhibitors and Potential Applications.
AID767571Cytotoxicity against human A549 cells after 2 days by AlamarBlue assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Herbimycins D-F, ansamycin analogues from Streptomyces sp. RM-7-15.
AID1224777Delta TM value showing the stabilisation of MST4(1) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID87629The compound was tested for binding affinity against isolated N-domain of Heat shock protein HSP 901999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
AID1389901Inhibition of HSP90alpha in human A549 cells assessed as upregulation of HSP90alpha expression at 5 to 10 uM after 24 hrs by Western blot analysis2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1225607Inhibition of HSP90 in human MCF7 cells assessed as Her2 degradation at 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID247226Inhibition of HCT116 human colon cancer cell proliferation2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.
AID103418Inhibition of steady-state expression of Raf-1 in MCF-7 breast cancer cells1999Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
Synthesis and evaluation of geldanamycin-estradiol hybrids.
AID1659863Antibacterial activity against Staphylococcus aureus2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID314499Binding affinity at purified Hsp90 by DELFIA assay2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID608901Antiproliferative activity against human HCT116 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
AID580561Antiviral activity against Hepatitis C virus genotype 1b Con1 infected in human HuH7 cells assessed as GAPDH RNA or 18S rRNA level after 3 days selected with 40 nM HCV-796 and 800 nM boceprevir by qRT-PCR analysis2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
AID1659869Cytotoxicity against human K562 cells assessed as reduction in cell viability2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1863184Inhibition of HDAC6 in human NCI-H1975 cells assessed as increase in acetylation of alpha tubulin at 1 uM incubated for 24 hrs by western blot analysis2022European journal of medicinal chemistry, Oct-05, Volume: 240Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay.
AID1128881Binding affinity to N-terminal FLAG-tagged human recombinant HSP90alpha expressed in Escherichia coli BL21(DE3) by microscale thermophoresis assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
AID1074618Inhibition of HSP90 in human CL1-5 cells assessed as reduction of slug expression after 16 hrs by Western blotting analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis.
AID114896In vivo inhibition of phospho-p185erbB-2 expression in human SK-BR-3 tumors at 100 mg/kg ip dose in mice1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
AID684674Cytotoxicity against human HepG2 cells2012Journal of natural products, Aug-24, Volume: 75, Issue:8
Identification of 4,5-dihydro-4-hydroxygeldanamycins as shunt products of geldanamycin biosynthesis.
AID1128880Binding affinity to N-terminal FLAG-tagged human recombinant HSP90beta expressed in Escherichia coli BL21(DE3) by microscale thermophoresis assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
AID497864Inhibition of human RIP1 K45M mutant autophosphorylation expressed in Sf9 cells at 10 to 30 uM2008Nature chemical biology, May, Volume: 4, Issue:5
Identification of RIP1 kinase as a specific cellular target of necrostatins.
AID1181926Inhibition of HSP90 in human MDA-kb2 cells assessed as reduction in glucocorticoid receptor-dependent luciferase expression after 18 hrs by firefly luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
AID656628Cytotoxicity against human MCF7 cells at 72 hrs by MTS assay2011ACS medicinal chemistry letters, Oct-13, Volume: 2, Issue:10
Monoenomycin: A Simplified Trienomycin A Analogue that Manifests Anticancer Activity.
AID88864Compound was evaluated for antiproliferative activity against human ovarian carcinoma cell line A2780.2001Bioorganic & medicinal chemistry letters, Aug-20, Volume: 11, Issue:16
Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems.
AID606868Inhibition of Cdc37 interaction with heme-regulated [35S]His-tagged eIF2alpha K199R mutant kinase in reticulocyte lysate assessed as coadsorbed Cdc37 at 80 uM after 40 mins by SDS-PAGE and Western blot analysis2011Journal of natural products, May-27, Volume: 74, Issue:5
Gambogic acid, a natural product inhibitor of Hsp90.
AID1740800Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1224760Delta TM value showing the stabilisation of CHEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347240Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID598614Antiproliferative activity against human U87 cells by luminescence assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID1177512Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTS/PMS assay relative to DNSO-treated control2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A.
AID383450Inhibition of ATPase activity of yeast Hsp902008Journal of medicinal chemistry, May-08, Volume: 51, Issue:9
Molecular characterization of macbecin as an Hsp90 inhibitor.
AID115734In vivo inhibition of p185 phosphotyrosine in nu/nu nude mice bearing Fisher rat embryo cells transfected with human erbB-2 (inactive)1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.
AID598611Inhibition of HSP90alpha after 3 hrs by fluorescence polarization binding assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID1650611Inhibition of HSP90 in human MCF7 cells assessed as HSP70 level at 10 uM incubated for 24 hrs by immunoblotting assay (Rvb = 1 No_unit)2020Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
Identification of vibsanin A analog as a novel HSP90 inhibitor.
AID1306536Anticancer activity against human HCT116 cells measured after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Design, synthesis, and anticancer activity of C8-substituted-4'-thionucleosides as potential HSP90 inhibitors.
AID1224806Delta TM value showing the stabilisation of VRK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1128884Antiplasmodial activity against Plasmodium falciparum NF54 infected in human erythrocytes assessed as growth inhibition by [3H]hypoxanthine incorporation assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
AID1224798Delta TM value showing the stabilisation of DRAK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1338340Induction of apoptosis in gefitinib-resistant human NCI-H1975 cells assessed as early apoptotic cells at 1 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 1.85%)2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID595269Inhibition of HSP90 dependent refolding of heat denatured firefly luciferase in rabbit reticulocyte lysate after 30 mins2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1659861Antibacterial activity against Bacillus amyloliquefaciens2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1740803Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human SK-OV-3 cells2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1318681Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors.
AID1751333Cytotoxicity against human RWPE-1 cells
AID273348Cytotoxicity against human LS174T cells by MTS assay2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.
AID567625Inhibition of HSP90 binding to Cdc37 in human SKBR-3 cells 1 mM by Western blotting2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID606951Effect on [35S]His-tagged HRI stability in heme-deficient reticulocyte lysate assessed as loss of [35S]His-tagged HRI at 80 uM after 45 mins by SDS-PAGE and autoradiography2011Journal of natural products, May-27, Volume: 74, Issue:5
Gambogic acid, a natural product inhibitor of Hsp90.
AID1751336Cytotoxicity against human C42B cells
AID606866Inhibition of Hsp90 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Hsp90 at 80 uM after 40 mins by SDS-PAGE and Western blot analysis2011Journal of natural products, May-27, Volume: 74, Issue:5
Gambogic acid, a natural product inhibitor of Hsp90.
AID1389869Inhibition of Hsp90/Cdc37 interaction in human A549 cells assessed as downregulation of Cdc37 in immunoprecipitated HSP90 complex at 10 uM after 24 hrs by Western blot analysis2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1167275Inhibition Hsp90 in human MDA-MB 231 cells assessed as increase in HSP70 protein level at 0.5 uM incubated for 24 hrs by Western blot method2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID347247Binding affinity to human recombinant MAP2K6 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1627900Antiproliferative activity against human MCF7 assessed as reduction in cell viability measured after 96 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID350568Binding affinity to human recombinant HSP902009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Potent cytotoxic C-11 modified geldanamycin analogues.
AID312949Inhibition of human Hsp90-alpha by fluorescence polarization assay2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
AID745742Aqueous solubility of the compound2013Journal of natural products, May-24, Volume: 76, Issue:5
19-[(1'S,4'R)-4'-Hydroxy-1'-methoxy-2'-oxopentyl]geldanamycin, a natural geldanamycin analogue from Streptomyces hygroscopicus 17997.
AID314503Growth inhibition of human HCT116 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1155476Antiplasmodial activity against Plasmodium falciparum Dd2 harboring HSP90 mutant2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
AID1181927Cytotoxicity against human MDA-kb2 cells assessed as reduction in cell viability after 18 hrs by Promega cell titer-Glo assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
AID114903In vivo inhibition of phospho-p185erbB-2 expression in human SK-BR-3 tumors at 50 mg/kg ip dose in mice1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
AID1224805Delta TM value showing the stabilisation of VRK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1348002Binding affinity to HSP90alpha in HEK293T cells assessed as integrated protein density by measuring HSP90alpha to beta actin density ratio at 10 uM incubated for 3 hrs followed by heating at 55 degC for 3 min then subsequent cooling for 3 mins by Western 2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and pharmacological evaluation of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-N-arylmethyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamides as potent Hsp90 inhibitors.
AID314502Induction of human K562 cells differentiation2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID567635Modulation proteolytic fingerprint of HSP90 in rabbit reticulocyte lysates at 10 ug/ml after 5 mins by SDS-PAGE analysis in presence of 125 ug/ml of trypsin2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID1224756Delta TM value showing the stabilisation of CAMKK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1187076Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Oct-06, Volume: 85Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
AID244290Effective concentration for Her-2 degradation in SKBR-3 cells2005Bioorganic & medicinal chemistry letters, Mar-01, Volume: 15, Issue:5
Crystal structures of human HSP90alpha-complexed with dihydroxyphenylpyrazoles.
AID1073051Reactivation of latent HIV1 NL4-3-Luc expression in human naive CD4+ T cells treated 7 days post-infection measured after 48 hrs by luminescence plate reader analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
AID598612Inhibition of v-Src by cell-based functional assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID1225614Inhibition of HSP90 in human MCF7 cells assessed as induction of heat shock response-mediated HSP27 production at 5 times IC50 after 24 hrs by Western blot analysis relative to vehicle-treated control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1167287Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID656627Cytotoxicity against human HeLa cells at 72 hrs by MTS assay2011ACS medicinal chemistry letters, Oct-13, Volume: 2, Issue:10
Monoenomycin: A Simplified Trienomycin A Analogue that Manifests Anticancer Activity.
AID307450Cell viability of mouse P19 derived neurons at 1 nM by XTT reduction assay relative to control2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
AID765336Cell cycle arrest in human SKBR3 cells assessed as accumulation at G2/M phase at 0.5 uM after 48 hrs by flow cytometric analysis (Rvb = 21 +/- 1%)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1224749Delta TM value showing the stabilisation of CAMK1D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID114901In vivo inhibition of phospho-p185erbB-2 expression in human SK-BR-3 tumors at 400 mg/kg dose in mice (lethal)1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
AID595298Inhibition of Hsp90-dependent maturation of [35S]-labeled His-tagged eIF2alpha in rabbit reticulocyte lysate at 1 ug/ml by anti-His-tag pull down assay2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1167283Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID1885314Inhibition of KDM4B (unknown origin) measured by AlphaScreen assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Recent Advances with KDM4 Inhibitors and Potential Applications.
AID1224766Delta TM value showing the stabilisation of CK1G3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1155477Antiplasmodial activity against Plasmodium falciparum Dd2 harboring CRT mutant2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
AID1224758Delta TM value showing the stabilisation of CDK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID765346Inhibition of HSP90 in mouse 3T3-Y9-B12 cells assessed as activation of HSF1 at 0.5 uM after overnight incubation by GFP reporter gene assay relative to control2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1225609Inhibition of HSP90 in human MCF7 cells assessed as Raf degradation at 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID753314Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 72 hrs2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Synthesis and preliminary evaluation steroidal antiestrogen-geldanamycin conjugates.
AID307454Therapeutic index, ratio of neurotoxic IC50 to neuroprotective activity for mouse P19 derived neurons2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
AID430855Cytotoxicity against human MCF7 cells by SRB assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Identification of new Hsp90 inhibitors by structure-based virtual screening.
AID745743Cytotoxicity against human HepG2 cells by MTT assay2013Journal of natural products, May-24, Volume: 76, Issue:5
19-[(1'S,4'R)-4'-Hydroxy-1'-methoxy-2'-oxopentyl]geldanamycin, a natural geldanamycin analogue from Streptomyces hygroscopicus 17997.
AID1631711Binding affinity to recombinant Plasmodium falciparum Hsp90 expressed in Escherichia coli BL21(DE3) pLysS by microscale thermophoresis assay2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles.
AID1659867Cytotoxicity against human MCF7 cells assessed as reduction in cell viability2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1336863Neuritogenic activity in mouse P19 derived neurons assessed as increase in neurite number at 1 nM after 18 hrs by phase contrast microscopic method relative to control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Neuritogenic activity of bi-functional bis-tryptoline triazole.
AID1187077Hepatotoxicity in Kunming mouse assessed as serum AST level at 10 mg/kg, iv (Rvb = 197.2 +/- 11.2 U/L)2014European journal of medicinal chemistry, Oct-06, Volume: 85Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
AID1512189Inhibition of HSP90 N-terminal in human SKBR3 cells assessed as induction of heat shock response by measuring increase in HSP70 protein level incubated for 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 11-15, Volume: 29, Issue:22
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
AID311889Effect on binding of Hsp90 to HR1 relative to control2007Journal of natural products, Dec, Volume: 70, Issue:12
Derrubone, an inhibitor of the Hsp90 protein folding machinery.
AID1751332Cytotoxicity against human MDA-MB-231 cells
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1225605Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTS/PMS assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1224797Delta TM value showing the stabilisation of MPSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID598619Half life in human liver microsomes2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID753312Antiproliferative activity against estrogen receptor deficient human SKBR3 cells after 72 hrs2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Synthesis and preliminary evaluation steroidal antiestrogen-geldanamycin conjugates.
AID1740796Antiproliferative activity against human SK-BR-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1659858Antibiofilm activity against Bacillus amyloliquefaciens2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID347249Binding affinity to human recombinant PLK4 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1503827Growth inhibition of human RPMI8226 cells after 72 hrs by MTS/PMS assay2017ACS medicinal chemistry letters, Oct-12, Volume: 8, Issue:10
Resorcinol-Based Grp94-Selective Inhibitors.
AID307453Neuroprotective activity against paclitaxel-induced toxicity in mouse P19 derived neurons assessed as cell viability at 1 nM2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
AID1224773Delta TM value showing the stabilisation of ASK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID87628Binding affinity against Heat shock 90 KD protein (Hsp90)2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Inhibition of protein-protein association by small molecules: approaches and progress.
AID1187075Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Oct-06, Volume: 85Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1512193Inhibition of HSP90 at N-terminus in human SKBR3 cells assessed as induction of AKT protein degradation incubated for 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 11-15, Volume: 29, Issue:22
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
AID103416Inhibition of steady-state expression of ER in MCF-7 breast cancer cells1999Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
Synthesis and evaluation of geldanamycin-estradiol hybrids.
AID1721929Inhibition of HSP90 in human BT-474 cells assessed as reduction in HSP70 expression at 0.3 uM incubated for 24 hrs by DAPI staining based confocal microscopy2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).
AID1280898Inhibition of Hsp90 in human A549 cells assessed as decrease in C-Raf levels at five times IC50 value after 12 to 24 hrs by Western blot analysis2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Novobiocin Analogues That Inhibit the MAPK Pathway.
AID1224782Delta TM value showing the stabilisation of PAK5 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID767752Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from dog Grp94 after 24 hrs by fluorescence polarization assay2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.
AID1268204Increase in intracellular D-aspartate content in HEK293 cells at 5 ug after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis relative to total aspartate (Rvb = 7.38 +/- 1.9%)2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID332868Herbicidal activity against Lepidium sativum assessed as inhibition of radicle growth of seed at 3 to 4 ppm after 69 to 75 hrs in dark
AID765351Inhibition of HSP90 in human SKBR3 cells assessed as aggregation of intracellular HER2 at 0.5 uM after 18 hrs by DAPI staining-based immunofluorescence microscopic analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID499308Antiproliferative activity against human A431 cells after 72 hrs2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID1268221Effect on L-aspartate biosynthesis in rat PC12 cells assessed as effect on intracellular L-aspartate level up to 10 uM after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1224775Delta TM value showing the stabilisation of ERK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID114898In vivo inhibition of phospho-p185erbB-2 expression in human SK-BR-3 tumors at 200 mg/kg dose ip in mice1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
AID309727Inhibition of yeast Hsp90 ATPase expressed in Escherichia coli2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
AID617927Inhibition of Hsp90 in human MCF7 cells assessed as induction of Raf degradation at 500 nM after 24 hrs by Western blot method2011Journal of medicinal chemistry, Sep-22, Volume: 54, Issue:18
Targeting the heat shock protein 90 dimer with dimeric inhibitors.
AID1224748Delta TM value showing the stabilisation of AMPKA2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID598613Antiproliferative activity against human HCT116 cells by luminescence assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID1224800Delta TM value showing the stabilisation of MST4 (2) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1627909Displacement of fluorescent labelled-VER00051001 from N-terminal ATP-binding site of human recombinant HSP90A expressed in Escherichia coli measured after 44 hrs by fluorescence polarization assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID1224770Delta TM value showing the stabilisation of JAK1~B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID591315Aqueous solubility of the compound2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.
AID598622Inhibition of human ERG by HT patch clamp assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID617924Inhibition of Hsp90 in human MCF7 cells assessed as induction of Her2 degradation at 500 nM after 24 hrs by Western blot method2011Journal of medicinal chemistry, Sep-22, Volume: 54, Issue:18
Targeting the heat shock protein 90 dimer with dimeric inhibitors.
AID767754Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from HSP90alpha (unknown origin) after 24 hrs by fluorescence polarization assay2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.
AID350567Cytotoxicity against human SKBR3 cells after 72 hrs by celltiter-glo assay2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Potent cytotoxic C-11 modified geldanamycin analogues.
AID1187081Inhibition of HSP90 in human MDA-MB 231 cells assessed increase in HSP70 protein levels at 0.5 and 5 uM by Western blot method2014European journal of medicinal chemistry, Oct-06, Volume: 85Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
AID1663548Antiproliferative activity against human CNE2Z cells assessed as cell growth inhibition by MTT assay2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
AID1525526Binding affinity to Heat Shock Protein 90 (unknown origin)2019Journal of medicinal chemistry, 11-27, Volume: 62, Issue:22
Why Some Targets Benefit from beyond Rule of Five Drugs.
AID1659865Inhibition of HSP90alpha (unknown origin)2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID347254Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1280896Inhibition of Hsp90 in human A549 cells assessed as decrease in EGFR levels at five times IC50 value after 12 to 24 hrs by Western blot analysis2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Novobiocin Analogues That Inhibit the MAPK Pathway.
AID1338349Antiproliferative activity against Her2-overexpressing human SKBR3 cells after 1 to 3 days by MTS assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID606945Inhibition of Hsp90-mediated [35S]His-tagged HRI maturation in heme-deficient reticulocyte lysate at 80 uM after 45 mins by SDS-PAGE and autoradiography2011Journal of natural products, May-27, Volume: 74, Issue:5
Gambogic acid, a natural product inhibitor of Hsp90.
AID1167281Cytotoxicity against human HL7702 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID1167282Cytotoxicity against human A549 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID1141019Displacement of GM-BODIPY from human full length HSP90 alpha expressed in baculovirus-infected Sf9 cells after 16 hrs by fluorescence polarization assay2014Bioorganic & medicinal chemistry letters, Jun-01, Volume: 24, Issue:11
Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization.
AID1280897Inhibition of Hsp90 in human A549 cells assessed as decrease in Her2 levels at five times IC50 value after 12 to 24 hrs by Western blot analysis2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Novobiocin Analogues That Inhibit the MAPK Pathway.
AID240503Inhibition of yeast Hsp90 ATPase activity2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.
AID1224768Delta TM value showing the stabilisation of DMPK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1659857Antibiofilm activity against Shewanella oneidensis MR-12020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1721931Inhibition of HSP90 in human JIMT-1 cells assessed as reduction in HSP70 expression at 0.3 uM incubated for 24 hrs by DAPI staining based confocal microscopy2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).
AID1224783Delta TM value showing the stabilisation of PAK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID247920Inhibitory concentration against human breast cancer MCF-7 cell lines2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
AID347250Binding affinity to human recombinant PAK6 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224761Delta TM value showing the stabilisation of CLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224776Delta TM value showing the stabilisation of ERK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1625307Inhibition of imatinib-resistant BCR-ABL T315I mutant (unknown origin) expressed in mouse BA/F3 cells assessed as decrease in cell viability after 48 hrs by trypan blue exclusion assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions.
AID347244Binding affinity to human recombinant STK3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID324582Increase in long-lived protein degradation in human H4 cells after 1 hr relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID598616Inhibition of CYP2D6 at 3 uM2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID608899Binding affinity to HSP90alpha after 3 hrs by fluorescence polarization assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
AID497871Inhibition of TNF-alpha-induced NF-kappaB activation expressed in FADD deficient human Jurkat cells by luciferase reporter gene assay2008Nature chemical biology, May, Volume: 4, Issue:5
Identification of RIP1 kinase as a specific cellular target of necrostatins.
AID311881Inhibition of Hsp902007Journal of natural products, Dec, Volume: 70, Issue:12
Derrubone, an inhibitor of the Hsp90 protein folding machinery.
AID314504Growth inhibition of human DLD1 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID598617Inhibition of CYP3A4 at 3 uM2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID1212931Drug metabolism in human liver microsomes assessed as stability during first 5 mins relative to control in presence of reduced GSH by liquid chromatography-tandem mass spectrometry2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes.
AID1659859Antibiofilm activity against Staphylococcus aureus2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1751337Cytotoxicity against human 22Rv1 cells
AID591314Metabolic stability in rat liver microsomes assessed as half life2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.
AID503316Antiproliferative activity against human PC3 cells at 2.5 uM after 120 hrs by MTT assay relative to DMSO2006Nature chemical biology, Jun, Volume: 2, Issue:6
Identifying off-target effects and hidden phenotypes of drugs in human cells.
AID1885317Inhibition of KDM6B (unknown origin) measured by AlphaScreen assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Recent Advances with KDM4 Inhibitors and Potential Applications.
AID1224788Delta TM value showing the stabilisation of PIM3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID307451Neurotoxicity against mouse P19 derived neurons after 18 hrs2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
AID598618Aqueous solubility of the compound2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID347236Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1650614Effect on HSP90 level in human MCF7 cells at 10 uM incubated for 24 hrs by immunoblotting assay (Rvb = 1 No_unit)2020Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
Identification of vibsanin A analog as a novel HSP90 inhibitor.
AID1627899Antiproliferative activity against human SW1990 assessed as reduction in cell viability measured after 96 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID1225608Inhibition of HSP90 in human MCF7 cells assessed as Cdk6 degradation at 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1224753Delta TM value showing the stabilisation of CAMK2D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID497862Inhibition of human RIP1 K45M mutant autophosphorylation expressed in FADD deficient human Jurkat cells at 10 to 30 uM2008Nature chemical biology, May, Volume: 4, Issue:5
Identification of RIP1 kinase as a specific cellular target of necrostatins.
AID765360Cell cycle arrest in human SKBR3 cells assessed as accumulation at G0/G1 phase at 0.5 uM after 48 hrs by flow cytometric analysis (Rvb = 54 +/- 2%)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1754440Inhibition of HSP90alpha C-terminal domain (unknown origin) assessed as reduction in HSP90 binding to PPID at 100 uM by AlphaScreen microplate reader analysis2021Bioorganic & medicinal chemistry letters, 08-01, Volume: 45Discovery of a simplified deguelin analog as an HSP90 C-terminal inhibitor for HER2-positive breast cancer.
AID567636Inhibition of HSP90 in human MCF7 cells assessed as degradation of Her2 protein after 48 hrs by Western blotting2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID324581Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 8 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1625308Inhibition of imatinib-resistant BCR-ABL E255K mutant (unknown origin) expressed in mouse BA/F3 cells assessed as decrease in cell viability after 48 hrs by trypan blue exclusion assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions.
AID606867Inhibition of Hsp70 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Hsp70 at 80 uM after 40 mins by SDS-PAGE and Western blot analysis2011Journal of natural products, May-27, Volume: 74, Issue:5
Gambogic acid, a natural product inhibitor of Hsp90.
AID1167274Inhibition of GA-FITC binding to human recombinant Hsp90alpha incubated for 5 hrs by fluorescence polarization assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID1268226Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of intracellular D-aspartate content at 10 uM measured at 1 hr by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis relative to vehicle-treated 2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1659866Cytotoxicity against human A549 cells assessed as reduction in cell viability2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1336862Neuritogenic activity in mouse P19 derived neurons assessed as increase in neurite length at 1 nM after 18 hrs by phase contrast microscopic method relative to control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Neuritogenic activity of bi-functional bis-tryptoline triazole.
AID1224802Delta TM value showing the stabilisation of TNIK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID580563Antiviral activity against Hepatitis C virus genotype 1b Con1 infected in human HuH7 cells assessed as GAPDH RNA or 18S rRNA level after 3 days by qRT-PCR analysis2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
AID201635In vitro inhibition of p185 erbB-2 oncoprotein in human breast cancer SK-BR-3 cells1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.
AID591313Antiproliferative activity against human HCT116 cells measured on day 4 by Cell titer-glo assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.
AID248052Inhibitory concentration against human colorectal carcinoma HT-29 cell lines2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
AID1740801Cytotoxicity against human HDF cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1224767Delta TM value showing the stabilisation of DAPK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224762Delta TM value showing the stabilisation of CLK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1338350Antiproliferative activity against gefitinib-resistant human NCI-H1975 cells after 1 to 3 days by MTS assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID347242Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID324580Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1224771Delta TM value showing the stabilisation of MEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224799Delta TM value showing the stabilisation of NDR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1627901Antiproliferative activity against human HCT116 assessed as reduction in cell viability measured after 96 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID1224787Delta TM value showing the stabilisation of PIM2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1390961Inhibition of geldanamycin-based probe binding to HSP90 (unknown origin) by fluorescence polarization assay2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90).
AID1889480Inhibition of HSP90 chaperone activity in human HeLa cell lysate assessed as suppression of denatured recombinant firefly luciferase refolding at 100 uM measured upto 60 mins by luminescence based microplate reader2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Elucidation of structure-activity relationship of humulanolides and identification of humulanolide analog as a novel HSP90 inhibitor.
AID1627908Displacement of fluorescent labelled-VER00051001 from N-terminal ATP-binding site of human recombinant HSP90A expressed in Escherichia coli measured after 32 hrs by fluorescence polarization assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID314500Inhibition of Hsp90 in human KPL4 cells assessed as depletion of ErbB2 level after 40 hrs2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID608902Antiproliferative activity against human NCI-H1975 cells2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
AID1224790Delta TM value showing the stabilisation of PLK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID444539Antiproliferative activity against human MCF7 cells2009Bioorganic & medicinal chemistry letters, Dec-15, Volume: 19, Issue:24
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors.
AID1708109Induction of heat shock response in human SK-BR-3 cells at 1 uM incubated for 18 hrs by Western blot analysis2021Journal of medicinal chemistry, 02-11, Volume: 64, Issue:3
The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with
AID1224793Delta TM value showing the stabilisation of RSK2a produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224785Delta TM value showing the stabilisation of PDK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324498Increase in light chain 3-GFP+ autophagosome vesicle area per cell in human H4 cells at 4.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID201632Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-3 cells) at 50 mg/kg dose.1995Journal of medicinal chemistry, Sep-15, Volume: 38, Issue:19
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
AID1224781Delta TM value showing the stabilisation of PAK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1663549Antiproliferative activity against human SMMC7721 cells assessed as cell growth inhibition by MTT assay2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
AID1225612Inhibition of HSP90 in human MCF7 cells assessed as induction of heat shock response-mediated HSP90 production at 5 times IC50 after 24 hrs by Western blot analysis relative to vehicle-treated control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID247814Inhibitory concentration against human leukemia K562 cell lines2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
AID1659860Antibacterial activity against Shewanella oneidensis MR-12020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Ansamycin derivatives from the marine-derived Streptomyces sp. SCSGAA 0027 and their cytotoxic and antiviral activities.
AID1155478Antiplasmodial activity against Plasmodium falciparum Dd2 harboring CYTb-Qi mutant2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
AID1225629Inhibition of HSP90 in human MCF7 cells assessed as disruption of interaction with p23 at 5 times IC50 after 24 hrs by co-immunoprecipitation assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1627906Displacement of fluorescent labelled-VER00051001 from N-terminal ATP-binding site of human recombinant HSP90A expressed in Escherichia coli measured after 20 hrs by fluorescence polarization assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID1338338Induction of apoptosis in gefitinib-resistant human NCI-H1975 cells assessed as necrotic cells at 1 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 2.68%)2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID1212928Drug metabolism in human liver microsomes assessed as stability after 2 hrs relative to control by liquid chromatography-tandem mass spectrometry2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes.
AID1155474Antiplasmodial activity against Plasmodium falciparum Dd22014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
AID1401931Inhibition of FITC-geldanamycin binding to N-terminal domain of recombinant full-length HSP90alpha (unknown origin) after 16 hrs by fluorescence polarization assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of a series of resorcinol-based N-benzyl benzamide derivatives as potent Hsp90 inhibitors.
AID1401933Antiproliferative activity against human NCI-H1975 cells after 72 hrs by Cell Titer 96 Aqueous One Solution cell proliferation assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of a series of resorcinol-based N-benzyl benzamide derivatives as potent Hsp90 inhibitors.
AID314506Growth inhibition of human KPL4 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1167271Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID465290Binding affinity to HSP902010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Heat shock protein 90: inhibitors in clinical trials.
AID767753Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant HSP90beta (unknown origin) after 24 hrs by fluorescence polarization assay2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.
AID1760003Cytotoxicity against mouse 661W cells by MTT based vision related toxicity assay2021European journal of medicinal chemistry, Jul-05, Volume: 219Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo.
AID1889473Induction of cell morphological changes in human HT-1080 cells at 10 uM incubated for 24 hrs by phase contrast microscopic analysis2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Elucidation of structure-activity relationship of humulanolides and identification of humulanolide analog as a novel HSP90 inhibitor.
AID1224786Delta TM value showing the stabilisation of PIM1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1751338Cytotoxicity against human H446 cells
AID243471Inhibition of yeast Hsp90 ATPase activity at 40 uM2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.
AID1390964Inhibition of HSP90alpha (unknown origin)2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90).
AID347241Binding affinity to human recombinant DYRK1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1858856Antiplasmodial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as growth inhibition2021European journal of medicinal chemistry, Jan-15, Volume: 210Antimalarial application of quinones: A recent update.
AID299071Antiproliferative activity against MCF7 cells2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity.
AID299074Cytotoxicity against rat neuronal cells at 10 uM after 24 hrs2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity.
AID1224803Delta TM value showing the stabilisation of PBK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224784Delta TM value showing the stabilisation of PCTK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347246Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1740804Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human PC-3 cells2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1268207Effect on L-aspartate biosynthesis in rat PC12 cells assessed as effect on total L-aspartate level up to 10 uM after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1224765Delta TM value showing the stabilisation of CK1G2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347239Binding affinity to human recombinant MAPK6 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID383449Binding affinity to yeast Hsp90 by isothermal titration calorimetry2008Journal of medicinal chemistry, May-08, Volume: 51, Issue:9
Molecular characterization of macbecin as an Hsp90 inhibitor.
AID1128885Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
AID1625290Inhibition of Hsp90 in human SKBR3 cells2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions.
AID1740805Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human U-87 MG cells2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1663551Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition by MTT assay2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
AID347253Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID309728Growth inhibition of human MCF7 cells after days by SRB assay2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
AID1224795Delta TM value showing the stabilisation of SLK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID503293Inhibition of HSP90 expressed in HEK293 cells assessed as effect on Akt1:p27 interaction complexes by EYFP and/or YFP Venus fragment based reporter gene assay2006Nature chemical biology, Jun, Volume: 2, Issue:6
Identifying off-target effects and hidden phenotypes of drugs in human cells.
AID1155475Antiplasmodial activity against Plasmodium falciparum Dd2 harboring DHODH mutant2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
AID1212933Drug metabolism in human liver microsomes assessed as stability after 120 mins relative to control in presence of reduced GSH by liquid chromatography-tandem mass spectrometry2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes.
AID1300346Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability at 100 uM after 72 hrs by MTS/PMS assay2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.
AID1268211Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of intracellular D-aspartate content at 10 uM measured at 3 to 16 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis relative to vehicle-t2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1740806Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human A549 cells2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID347251Binding affinity to human recombinant Hsp90 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1754448Inhibition of HSP90 at N-terminus in human BT-474 cells assessed as increase in nuclear HSF1 protein level at 300 nM incubated for 24 hrs by immunostaining analysis2021Bioorganic & medicinal chemistry letters, 08-01, Volume: 45Discovery of a simplified deguelin analog as an HSP90 C-terminal inhibitor for HER2-positive breast cancer.
AID347255Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1338337Induction of apoptosis in gefitinib-resistant human NCI-H1975 cells assessed as late apoptotic cells at 1 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 2.79%)2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID1187078Hepatotoxicity in Kunming mouse assessed as serum ALT level at 10 mg/kg, iv (Rvb = 60.7 +/- 6.9 U/L)2014European journal of medicinal chemistry, Oct-06, Volume: 85Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
AID1300345Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTS/PMS assay2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.
AID1268219Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of intracellular D-aspartate level up to 10 uM after 24 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID567638Inhibition of human HSP90alpha expressed in yeast PP30 cells co-expressing HSF-lacZ reporter assessed as induction of heat shock response at 100 uM after 3 hrs2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
A systematic protocol for the characterization of Hsp90 modulators.
AID392672Toxicity in retinoic acid-differentiated human SH-SY5Y cells assessed as effect on cell morphology at 10 uM after 24 hrs by trypan blue exclusion method2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line.
AID248073Inhibitory concentration against human colorectal carcinoma SW620 cell lines2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
AID347237Binding affinity to human recombinant PIM3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1167272Hepatotoxicity in Kunming mouse assessed as serum aspartate aminotransferase level at 10 mg/kg, iv (Rvb = 197.2 +/- 11.2 U/L)2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID347245Binding affinity to human recombinant SLK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID391492Inhibition of Hsp90-mediated Raf degradation in human SKBR3 cells after 24 hrs by Western blot2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships.
AID1224794Delta TM value showing the stabilisation of RSK2b produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID598620Half life in mouse liver microsomes2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID1627903Antiproliferative activity against human BGC823 assessed as reduction in cell viability measured after 96 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID1338339Induction of apoptosis in gefitinib-resistant human NCI-H1975 cells assessed as viable cells at 1 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 92.68%)2016European journal of medicinal chemistry, Nov-29, Volume: 124Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
AID1389902Inhibition of HSP90beta in human A549 cells assessed as upregulation of HSP90beta expression at 5 to 10 uM after 24 hrs by Western blot analysis2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1224757Delta TM value showing the stabilisation of CDK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1167273Hepatotoxicity in Kunming mouse assessed as serum alanine aminotransferase level at 10 mg/kg, iv (Rvb = 60.7 +/- 6.9U/L)2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID1318682Antiproliferative activity against human HeLa cells after 72 hrs by SRB assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors.
AID332872Toxicity in ip dosed mouse
AID87630The compound was tested for binding affinity against yeast Heat shock protein HSP 901999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
AID1224778Delta TM value showing the stabilisation of NEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1181925Inhibition of HSP90 in rabbit reticulocyte lysate after 90 mins by luciferase renaturation assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
AID1074619Inhibition of HSP90 in human CL1-5 cells assessed as reduction of phosphorylated Akt after 16 hrs by Western blotting analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis.
AID1224769Delta TM value showing the stabilisation of GSK3B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1885315Inhibition of KDM4C (unknown origin) measured by AlphaScreen assay2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Recent Advances with KDM4 Inhibitors and Potential Applications.
AID1318683Induction of thermal stabilization of Hsp90alpha in human 293T cells assessed as ratio of HSP90alpha to beta-actin integrated density at 10 uM preincubated for 3 hrs followed by 3 hrs of heating at 55 degC and subsequently 3 hrs of cooling at room tempera2016European journal of medicinal chemistry, Oct-04, Volume: 121Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors.
AID1889479Effect on CDK4 mRNA expression in human HT-1080 cells at 1 uM incubated for 24 hrs by semi-quantitative RT-PCR analysis2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Elucidation of structure-activity relationship of humulanolides and identification of humulanolide analog as a novel HSP90 inhibitor.
AID392674Neuroprotection against beta-amyloid peptide 1-42-induced toxicity in retinoic acid-differentiated human SH-SY5Y cells assessed as lactate dehydrogenase release at 10 nM2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line.
AID765339Cell cycle arrest in human SKBR3 cells assessed as accumulation at S phase at 0.5 uM after 48 hrs by flow cytometric analysis (Rvb = 19 +/- 6%)2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1224755Delta TM value showing the stabilisation of CAMK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID222128Inhibition of proliferation in NCI panel of 60 human cell lines (Range is 20-80 uM)2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Structural studies on bioactive compounds. 32. Oxidation of tyrphostin protein tyrosine kinase inhibitors with hypervalent iodine reagents.
AID777311Cytotoxicity against human BT474 cells at 0.05 to 0.25 uM after 48 hrs by WST-1 assay2013ACS medicinal chemistry letters, Oct-10, Volume: 4, Issue:10
A structurally simplified analogue of geldanamycin exhibits neuroprotective activity.
AID1650612Inhibition of HSP90 in human MCF7 cells assessed as CDK4 level at 10 uM incubated for 24 hrs by immunoblotting assay (Rvb = 1 No_unit)2020Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
Identification of vibsanin A analog as a novel HSP90 inhibitor.
AID1074617Inhibition of HSP90 in human CL1-5 cells assessed as reduction of total Akt at 2 uM after 16 hrs by Western blotting analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis.
AID598621Half life in rat liver microsomes2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
AID497870Inhibition of TNF-alpha-induced NF-kappaB activation expressed in HEK293T cells by luciferase reporter gene assay2008Nature chemical biology, May, Volume: 4, Issue:5
Identification of RIP1 kinase as a specific cellular target of necrostatins.
AID395889Growth inhibition of human NCI60 cells at 13 nM2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery and development of heat shock protein 90 inhibitors.
AID1224774Delta TM value showing the stabilisation of p38beta produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID595264Inhibition of Hsp90 in human MCF7 cells assessed as Her2 degradation at 0.5 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1348003Antiproliferative activity against human A549 cells after 72 hrs by SRB assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and pharmacological evaluation of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-N-arylmethyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamides as potent Hsp90 inhibitors.
AID1224779Delta TM value showing the stabilisation of NEK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224764Delta TM value showing the stabilisation of CK1G1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1128879Binding affinity to N-terminal FLAG-tagged Plasmodium falciparum recombinant HSP90 (1 to 223) expressed in Escherichia coli BL21(DE3) by microscale thermophoresis assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
AID1224751Delta TM value showing the stabilisation of CAMK2A produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1167280Cytotoxicity against HUVEC cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID1224763Delta TM value showing the stabilisation of CLK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID332870Herbicidal activity against Lepidium sativum assessed as inhibition of radicle growth of seeds at 1 to 2 ppm after 69 to 75 hrs in dark
AID1306534Anticancer activity against human A549 cells measured after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Design, synthesis, and anticancer activity of C8-substituted-4'-thionucleosides as potential HSP90 inhibitors.
AID324584Increase in long-lived protein degradation in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1224801Delta TM value showing the stabilisation of MST1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID324579Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID307452Cytotoxicity against mouse P19 cells after 18 hrs2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
AID324585Increase in long-lived protein degradation in human H4 cells after 24 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1187079Displacement of GA-FITC from human recombinant HSP90alpha ATP-binding site by fluorescence polarization assay2014European journal of medicinal chemistry, Oct-06, Volume: 85Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
AID1631715Binding affinity to recombinant Plasmodium falciparum Hsp90 ISG-LGA mutant expressed in Escherichia coli BL21(DE3) pLysS by microscale thermophoresis assay2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles.
AID314505Growth inhibition of human A549 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID311888Effect on binding of Cdc37 to HR1 relative to control2007Journal of natural products, Dec, Volume: 70, Issue:12
Derrubone, an inhibitor of the Hsp90 protein folding machinery.
AID324446Increase in light chain 3-GFP+ autophagosome vesicle number per cell in human H4 cells at 4.5 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1512188Inhibition of HSP90 N-terminal in human SKBR3 cells assessed as induction of heat shock response by measuring increase in HSP90 protein level incubated for 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 11-15, Volume: 29, Issue:22
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
AID1663550Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition by MTT assay2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
AID347257Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1225611Change in p23 expression in human MCF7 cells at 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1225613Inhibition of HSP90 in human MCF7 cells assessed as induction of heat shock response-mediated HSP70 production at 5 times IC50 after 24 hrs by Western blot analysis relative to vehicle-treated control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1740802Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human SK-BR-3 cells2020European journal of medicinal chemistry, Sep-15, Volume: 202Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
AID1181928Inhibition of HSP90 in human MDA-kb2 cells assessed as reduction in glucocorticoid receptor-dependent luciferase expression at <0.01 uM after 18 hrs by firefly luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
AID767751Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant human Trap-1 after 24 hrs by fluorescence polarization assay2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.
AID1306538Anticancer activity against human SNU638 cells measured after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Design, synthesis, and anticancer activity of C8-substituted-4'-thionucleosides as potential HSP90 inhibitors.
AID1512191Inhibition of HSP90 at N-terminus in human SKBR3 cells assessed as induction of CDK4 protein degradation incubated for 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 11-15, Volume: 29, Issue:22
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
AID765342Inhibition of HSP90 in rabbit reticulocyte lysate assessed as inhibition of heat-denatured luciferase refolding after 30 mins by luminescence plate reader analysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
AID1268212Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of total D-aspartate content at 10 uM measured at 6 to 16 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis relative to vehicle-treated c2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID1627902Antiproliferative activity against human A375 assessed as reduction in cell viability measured after 96 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID767566Displacement of FITC-linked geldanamycin from purified recombinant HSP90alpha (unknown origin) at 33 nM after 3 hrs by fluorescence polarization-based competition assay2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Herbimycins D-F, ansamycin analogues from Streptomyces sp. RM-7-15.
AID1268227Inhibition of D-aspartate biosynthesis in rat PC12 cells assessed as reduction of total D-aspartate content at 10 uM measured at 1 to 3 hrs by O-phthalaldehyde/N-acetyl-L-cysteine derivatization technique-based HPLC analysis relative to vehicle-treated co2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells.
AID595261Inhibition of Hsp90 in human MCF7 cells assessed as Akt degradation at 0.5 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
Identification and initial SAR of silybin: an Hsp90 inhibitor.
AID1650613Inhibition of HSP90 in human MCF7 cells assessed as HER2 level at 10 uM incubated for 24 hrs by immunoblotting assay (Rvb = 1 No_unit)2020Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
Identification of vibsanin A analog as a novel HSP90 inhibitor.
AID391491Inhibition of Hsp90-mediated HER2 degradation in human SKBR3 cells after 24 hrs by Western blot2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships.
AID1751341Selective index, ratio of IC50 for human RWPE1 to IC50 for human LNCaP C4-2B cells
AID1177511Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTS/PMS assay2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A.
AID617930Inhibition of Hsp90 in human MCF7 cells assessed as induction of Akt degradation at 500 nM after 24 hrs by Western blot method2011Journal of medicinal chemistry, Sep-22, Volume: 54, Issue:18
Targeting the heat shock protein 90 dimer with dimeric inhibitors.
AID1224780Delta TM value showing the stabilisation of OSR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224792Delta TM value showing the stabilisation of RIOK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224804Delta TM value showing the stabilisation of VRK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1167284Cytotoxicity against human A431 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Nov-24, Volume: 87Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
AID777309Cytotoxicity against human Friedreich's ataxia lymphocytes at 0.05 to 0.25 uM after 48 hrs by WST-1 assay2013ACS medicinal chemistry letters, Oct-10, Volume: 4, Issue:10
A structurally simplified analogue of geldanamycin exhibits neuroprotective activity.
AID347252Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1627907Displacement of fluorescent labelled-VER00051001 from N-terminal ATP-binding site of human recombinant HSP90A expressed in Escherichia coli measured after 29 hrs by fluorescence polarization assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1801076Fluorescence Polarization Assay (FPA) from Article 10.1111/cbdd.12371: \\Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.\\2015Chemical biology & drug design, Feb, Volume: 85, Issue:2
Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Inhibition of protein-protein association by small molecules: approaches and progress.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,213)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (0.41)18.7374
1990's124 (10.22)18.2507
2000's652 (53.75)29.6817
2010's383 (31.57)24.3611
2020's49 (4.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.09%)5.53%
Trials0 (0.00%)5.53%
Reviews63 (5.40%)6.00%
Reviews5 (5.21%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other1,103 (94.52%)84.16%
Other91 (94.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 1 Open-Label, Dose Escalation Study Evaluating the Safety and Tolerability of IPI-493 in Patients Experiencing Advanced Hematologic Malignancies With Client Proteins of Hsp90 [NCT01193491]Phase 14 participants (Actual)Interventional2010-06-30Terminated(stopped due to Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus on Retaspimycin HCL)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]